Beranda › Kondisi Pasca-COVID (Long COVID) › Ohio › Columbus
Uji klinis Kondisi Pasca-COVID (Long COVID) di Columbus, OH
5 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
- Research Site, Columbus
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
- Remington-Davis, Inc, Columbus
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
Menerima peserta
- The Ohio State University Wexner Medical Center, Columbus
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
Menerima pesertaFase 1/2
- Nationwide Children's Hosptial, Columbus
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Menerima pesertaFase 3
- The Ohio State University Wexner Medical Center, Columbus
Uji klinis Kondisi Pasca-COVID (Long COVID) di kota lain
- New York City, NY15 studi
- Houston, TX13 studi
- Boston, MA13 studi
- Baltimore, MD12 studi
- Chicago, IL11 studi
- Washington, DC10 studi
- San Francisco, CA8 studi
- Durham, NC8 studi
- Atlanta, GA8 studi
- San Diego, CA7 studi
- Los Angeles, CA6 studi
- Pittsburgh, PA6 studi
Studi lain di Columbus
- Kanker Paru Non-Sel Kecil57 studi
- Kanker Payudara40 studi
- Kanker Ovarium39 studi
- Kanker (semua jenis)38 studi
- Kanker Paru37 studi
- Leukemia Mieloid Akut35 studi
- Leukemia Limfositik Kronis28 studi
- Kanker Metastatik27 studi
- Kanker Endometrium25 studi
- Kanker Prostat24 studi
- Mieloma Multipel24 studi
- Kanker Kolorektal24 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.